2
艾迪药业：撤回注射用乌司他丁仿制药项目上市申请
source link: https://www.chinaipo.com/news/1082919.html
Go to the source link to view the article. You can view the picture content, updated content and better typesetting reading experience. If the link is broken, please click the button below to view the snapshot at that time.
艾迪药业：撤回注射用乌司他丁仿制药项目上市申请
艾迪药业(688488.SH)公告，决定撤回注射用乌司他丁仿制药项目上市申请。
2022年9月14日晚间，A股公司艾迪药业(688488.SH)公告，决定撤回注射用乌司他丁仿制药项目上市申请。公司已提交《关于注射用乌司他丁上市申请撤回函》申请撤回注射用乌司他丁的上市申请，并于近日收到《药品注册申请终止通知书》，同意终止注册程序。
头图来源：图虫
风险提示：资本邦呈现的所有信息仅作为参考，不构成投资建议，一切投资操作信息不能作为投资依据。投资有风险，入市需谨慎!
Recommend
About Joyk
Aggregate valuable and interesting links.
Joyk means Joy of geeK